Clinical spectrum of hemiplegic migraine and chances of finding a pathogenic mutation.

OBJECTIVE

To investigate whether the clinical characteristics of patients with hemiplegic migraine with and without autosomal dominant mutations in , , or differ, and whether the disease may be caused by mutations in other genes.

METHODS

We compared the clinical characteristics of 208 patients with familial (n = 199) or sporadic (n = 9) hemiplegic migraine due to a mutation in , , or with those of 73 patients with familial (n = 49) or sporadic (n = 24) hemiplegic migraine without a mutation in these genes. In addition, 47 patients (familial: n = 33; sporadic: n = 14) without mutations in , , or were scanned for mutations in novel genes using whole exome sequencing.

RESULTS

Patients with mutations in , , or had a lower age at disease onset, larger numbers of affected family members, and more often attacks (1) triggered by mild head trauma, (2) with extensive motor weakness, and (3) with brainstem features, confusion, and brain edema. Mental retardation and progressive ataxia were exclusively found in patients with a mutation. Whole exome sequencing failed to identify pathogenic mutations in new genes.

CONCLUSIONS

Most patients with hemiplegic migraine without a mutation in , , or display a mild phenotype that is more akin to that of common (nonhemiplegic) migraine. A major fourth autosomal dominant gene for hemiplegic migraine remains to be identified. Our observations might guide physicians in selecting patients for mutation screening and in providing adequate genetic counseling.